Amneal Pharmaceuticals, Inc. AMRX
Price alert —
Sign in to get a one-time email the moment AMRX crosses your price. Free accounts included.
Sign in / create a free accountAmneal Pharmaceuticals, Inc. is a healthcare company listed in the US.
AMRX last traded at $17.85, down 1.1% on the day; that's in the upper part of its 52-week range ($11.71–$18.39). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.
Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
On the latest daily bar, momentum sits mid-range (RSI 69), the trend is strong (ADX 30), and volume is about normal (0.9×). On the business side, revenue is growing 4% year over year and the business keeps about 3 cents of every sales dollar as free cash.
Latest-bar indicator readings behind the grade — display-only, they don't move the letter.
Company fundamentals for context — display-only, they don't move the grade.
Our cash-flow model pegs fair value near $-2.59 (fair range $-3–$28). The model's verdict is “Unknown” and accounting quality screens as Weak. Model estimates only — do your own due diligence.
- ✓ Current ratio 2.17 (antifragile)
- ⚠ Debt exceeds cash
- ⚠ Negative retained earnings
- ⚠ Receivables growing faster than revenue
Price implies ~32% growth (vs trailing rev yoy). Model estimate — do your own due diligence.
AMRX is a $5.8 billion company, priced at 49× last year's earnings, and the stock is trading near the top of its 52-week range.